Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 122.44 | 27.22 | - | - | - |
Total Expenses | 119.21 | 26.29 | - | - | - |
Profit Before Tax | 3.23 | 0.93 | - | - | - |
Profit After Tax | 2.46 | 0.70 | - | - | - |
Operating Profit after Depreciation | 6.31 | 1.70 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 0.91 | 0.85 | - | - | - |
Total Non Current Assets | 0.95 | 1.48 | - | - | - |
Total Current Assets | 80.16 | 61.12 | - | - | - |
TOTAL ASSETS | 81.11 | 62.60 | - | - | - |
Total Shareholder's Fund | 28.11 | 13.38 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -8.77 | -27.75 | - | - | - |
Net Cash used in Investing Activities | 0.40 | -1.44 | - | - | - |
Net Cash used in Financing Activities | 8.32 | 29.61 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 72.42 | 14.11 | - | - | - |
Total Expenses | 69.56 | 13.45 | - | - | - |
Profit Before Tax | 2.86 | 0.67 | - | - | - |
Profit After Tax | 2.44 | 0.54 | - | - | - |
Operating Profit after Depreciation | 4.07 | 1.04 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 0.14 | 0.19 | - | - | - |
Total Non Current Assets | 3.76 | 2.22 | - | - | - |
Total Current Assets | 41.64 | 26.84 | - | - | - |
TOTAL ASSETS | 45.40 | 29.07 | - | - | - |
Total Shareholder's Fund | 28.11 | 13.40 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -10.32 | -13.49 | - | - | - |
Net Cash used in Investing Activities | -1.66 | -2.18 | - | - | - |
Net Cash used in Financing Activities | 12 | 15.90 | - | - | - |
No data available
No data available
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Mono Pharmacare Ltd | ₹27.15 | ₹47.97 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
04 Jan 2025, 10:27 am
07 Nov 2024, 03:32 pm
11 Sep 2024, 05:22 pm
31 Aug 2024, 04:38 pm
31 Jul 2024, 01:51 pm